Physician profile
Jonathan Vandenberg
NPI 1730562422
$3,816.78
in general payments reported to CMS, 2019-2025
11 companies · $64.93 in 2025
The $64.93 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.66 · 2022: $1,612 · 2023: $1,943 · 2024: $185 · 2025: $64.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,411 · Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,411.07 |
| Food and Beverage | $781.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,911.45 | 2021-2024 | Synchromedii |
| Ipsen Pharma Sas | $1,463.13 | 2022 | |
| Abbvie INC. | $208.59 | 2022-2025 | Botox |
| Merz Pharmaceuticals, LLC | $56.26 | 2024 | Xeomin |
| Coloplast Corp | $33.45 | 2025 | |
| Tersera Therapeutics LLC | $32.48 | 2024 | Prialt |
| Boston Scientific Corporation | $25.54 | 2023 | Spyglass |
| Allergan, INC. | $23.46 | 2022 | |
| Dentsply Ih Ab | $23.04 | 2024 | Navina Rectal Catheter Set Regular |
| Piramal Critical Care | $20.92 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $18.46 | 2024 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Vandenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.